Robust Clustering Analysis of Genes Related to Age-related Macular Degeneration using RNA-Seq

Brayan Gutierrez, Rinki Ratnapriya, Arko Barman · 2026

Read Robust Clustering Analysis of Genes Related to Age-related Macular Degeneration using RNA-Seq by Brayan Gutierrez, Rinki Ratnapriya, Arko Barman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2604-25986.txt.

Introduction

Gutierrez, Ratnapriya, and Barman analyze RNA-Seq data from age-related macular degeneration patients and controls with robust clustering. Gene co-expression networks group genes into modules beyond single-gene links. The authors generalize the MEGENA framework. They curate quality metrics to pick similarity measures from statistical distance or information theory, not linear correlation. A stability test checks hub-gene robustness under noise. Differential module eigengene analysis tracks upregulation and downregulation per module. They confirm known hubs and modules, and find new hub genes for further research.

Catalog record

CREATORBrayan Gutierrez, Rinki Ratnapriya, Arko Barman
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47899
LICENSEhttp://creativecommons.org/licenses/by-sa/4.0/
RIGHTSCC BY SA
SOURCEarXiv

Source: https://arxiv.org/abs/2604.25986

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Robust Clustering Analysis of Genes Related to Age-related Macular Degeneration using RNA-Seq Brayan Gutierrez, Rinki Ratnapriya, Arko Barman Abstract Identifying genes associated with diseases is crucial to understanding disease mechanisms and developing therapies. However, identification of individual genes associated with a disease often needs to be supplemented with clustering analysis to understand the relationships between genes and identify gene modules beyond individual gene-level relationships. Gene co-expression networks are widely used as a graph theoretic approach to the clustering analysis of genes. In our work, we perform robust clustering analysis on RNA-Seq data of Age-related Macular Degeneration (AMD) patients and controls by generalizing one such framework, Multiscale Embedded Gene Co-Expression Network Analysis (MEGENA). We propose a carefully curated set of module quality evaluation metrics to choose appropriate statistical distance-based or information theoretic similarity measures over simple linear correlation to represent the similarities between genes. Furthermore, we design and implement a stability test to ensure the robustness of the detected hub genes in the presence of noise. Finally, we propose differential module eigengene analysis for a deeper understanding of upregulation and downregulation of each module with respect to the disease and control groups for a comprehensive understanding of the clustering analysis. Besides detecting robust hub genes and modules that are supported by prior findings, we also identify previously undiscovered hub genes that can potentially lead to further biomedical research into understanding the AMD disease mechanism and developing new treatments. I Introduction Age-related macular degeneration (AMD) is a progressive neurodegenerative disease that damages the macula, the retinal structure responsible for sharp central vision, color perception, and fine-detail recognition. AMD is the leading cause of irreversible vision loss in adults over the age of 50, affecting approximately 20 million individuals in the United States alone, with prevalence expected to increase substantially as the population ages. The disease manifests in two primary forms: dry (atrophic) AMD and wet (neovascular) AMD. Dry AMD, the more common form, is characterized by gradual thinning and degeneration of the macula and progresses through early, intermediate, and late stages, typically advancing slowly over time. Wet AMD is less common but more severe, and leads to accelerated vision loss. Importantly, late-stage dry AMD can progress further into wet AMD, underscoring the continuum of disease severity [ 26 , 25 ] . Furthermore, AMD is a complex, multifactorial disease shaped by the cumulative effects of aging, genetic predisposition, and environmental factors [ 9 , 8 ] . Despite extensive characterization of these risk factors, the molecular mechanisms underlying AMD progression and cellular vulnerability are incompletely understood [ 18 ] . However, in recent years, transcriptomics has emerged as a critical tool to identify genes associated with AMD [ 27 , 26 ] . Comparative transcriptomic studies in disease-relevant tissues offer a powerful tool to uncover molecular mechanisms underlying AMD. However, such analyses face substantial challenges, including limited sample availability, biological heterogeneity across donors, and the high dimensionality of gene expression data, all of which increase susceptibility to false positives and reduce reproducibility when using traditional statistical approaches [ 24 ] . These challenges have motivated the increasing use of machine learning (ML) approaches, which are well-suited to modeling complex interdependencies in large-scale gene expression datasets. Recent studies have demonstrated improved robustness in identifying genes related to AMD [ 18 , 24 ] . Such approaches enable the discovery of candidate genes that may contribute to disease risk or progression, but do not explicitly capture the coordinated structure of gene regulation underlying complex phenotypes. Since complex diseases such as AMD arise from coordinated dysregulation of gene networks rather than isolated gene effects, network-based approaches have become essential complements to understand gene clusters and disease mechanisms using gene co-expression networks [ 36 , 14 , 21 , 26 ] . Gene co-expression network analysis is widely used in transcriptomics to identify groups, clusters, modules, or communities of genes that exhibit similar expression patterns in different cohorts of subjects [ 26 , 21 , 20 ] . A co-expression network is a graph, \mathcal{G}=(\mathcal{V},\mathcal{E}) , where the nodes, \mathcal{V} , represent the genes and the edge weights, \mathcal{E} , represent the relationships between the genes. Most co-expression network construction strategies aim to make the network sparse rather than fully connected. As a result, the adjacency matrix of a co-expression network, \mathcal{A} , is a sparse matrix. Within co-expression modules, not all genes contribute equally to network structure or function. Thus, co-expression network analysis often focuses on identifying hub genes. Hub genes are defined as genes that occupy central positions within modules, characterized by high connectivity or centrality relative to other genes. From a systems biology perspective, hub genes are of particular interest because they may act as key regulators, signal integrators, or bottlenecks that coordinate the behavior of multiple downstream genes [ 10 , 3 , 5 ] . Most widely-used approaches for constructing and analyzing gene co-expression networks, such as Weighted Gene Co-expression Network Analysis (WGCNA) [ 13 ] , high-dimensional WGCNA [ 21 ] , and Multiscale Embedded Gene Co-Expression Network Analysis (MEGENA) [ 30 ] , assume only linear relationships between gene expressions and utilize only Pearson correlation. In our methods, we attempt to generalize this process by considering statistical distance metrics and information theoretic metrics that capture more nuanced information between the expression values of genes by treating gene expressions as random variables. Furthermore, we design a stability test to understand the effect of noise and ensure that our results and findings are robust and reliable. In this work, we identify robust hub genes for AMD using RNA-Seq data by generalizing MEGENA, a network-based framework designed to identify hierarchical, multiscale gene modules and associated hub genes from high-dimensional RNA-Seq data [ 30 , 29 ] . MEGENA constructs a planar filtered network (PFN) to preserve biologically meaningful relationships while reducing noise, and then recursively identifies modules and submodules that represent coordinated gene programs across multiple scales. This multiscale perspective is particularly well-suited for AMD, where dysregulated immune, metabolic, and neurovascular pathways interact across biological scales. To generalize the MEGENA framework, we identified the best similarity metrics for gene-gene comparisons while constructing a PFN using an extensive set of module quality evaluation metrics. Furthermore, we designed and performed tests to ensure the stability and robustness of our findings. In addition, we conducted Differential Module Eigengene (DME) analysis [ 21 ] to identify modules that are upregulated or downregulated in late AMD and control groups. Our contributions can be summarized as follows: • We identify the best similarity metric between genes for the construction of a Planar Filtered Network (PFN) using a curated set of module quality evaluation metrics. • We generalize Multiscale Embedded Gene Co-Expression Network Analysis (MEGENA) by leveraging statistical and information theoretic metrics instead of simple linear correlation to identify hierarchical, multiscale gene modules and associated hub genes related to AMD. • We design and perform stability tests to ensure that the process of identifying hub genes is robust. • We perform Differential Module Eigengene (DME) analysis on the gene modules to analyze which of the identified modules are upregulated or downregulated in the late AMD and control groups of subjects. II Related Work Advances in RNA-Seq technologies have enabled

Read the complete text